Jumet
Univercells
The Walloon biotechnology company Univercells in Jumet builds technology that can be used to produce vaccines and medicines quickly and cheaply.
Their need was clear: an ultramodern facility where they can produce just as many vaccines as the big players, but at a lower cost price and in a more compact production environment.
Jansen Cleanrooms & Labs was delighted to take on this assignment.
For the biotechnology company Univercells, we converted an old industrial building into an ultramodern facility for the development and production of viral vectors to be used as clinical trial material (CTM).
This project was carried out in two phases:
-
- Phase 1: demolition work and the creation of lab and GMP areas
(laboratories/cleanrooms: 1,600 m²) - Phase 2: creation of clean logistic areas (400 m²)
- Phase 1: demolition work and the creation of lab and GMP areas
Our specialist knowledge demonstrated. The end result is a new facility with a total surface area of 900 m² for GMP production areas, divided into Grade C and D environments. There is also a 320 m² GMP QC area, a 320 m² R&D area and a 400 m² clean logistic area, including coldrooms (4°C/-20°C/-40°C). In addition, we built an 800 m² technical area, equipped with ten air groups.
One thing is certain: this innovative company now operates in the best possible conditions!
It’s all about facts
And figures
Get in touch
Discover more
News
Redefining cleanroom innovation at Arab Health 2025
The Maastriathlon in Kinrooi received no fewer than 1,355 participants in the first weekend of July who showed their strongest side.
Maastriatlon, bring it on!
The Maastriathlon in Kinrooi received no fewer than 1,355 participants in the first weekend of July who showed their strongest side.
Group Jansen takes over Sumi
From now on, the West Flanders-based firm Sumi will be part of Group Jansen.
Discover more
Projects
Grand Hôpital de Charleroi
Jansen Cleanrooms & Labs is proud to have played a key role in the
Pivot Park – Marie Curie
At Pivot Park in Oss, the new Curie building has been completed after two
AP Hogeschool
On behalf of Kropman, Jansen Lab Solutions has completed the construction of a new
White Raven
Jansen Cleanrooms & Labs transformed a bare-shell space into a state-of-the-art cleanroom, a gowning
Ardena
On behalf of Kropman, Jansen Lab Solutions has completed the construction of a new
Sharp Services
The initial plan was to combine several smaller rooms into one Class D cleanroom.
Clinique Dr. Chapelle
Jansen Cleanrooms & Labs has delivered two modern operating theatres, fully compliant with ISO
Onze Lieve Vrouw hospital pharmacy
Imagine a space where precision meets patient care, where every detail is designed to
AZ Damiaan hospital pharmacy
A state-of-the-art cleanroom class D for both sterile and non-sterile preparations, including cytostatics production.
Johnson & Johnson Obelisc
Famous pharmaceutical companies call on Jansen Cleanrooms & Labs, as well. For the Obelisc project
Vaccinopolis
The climate is changing, people are living closer together, we are travelling more often
Univercells
The Walloon biotechnology company Univercells in Jumet builds technology that can be used to
Cytiva
To respond to the fast changing and evolving processes in biotechnology and advanced therapeutics,
ETpathfinder
The University of Maastricht enlisted Jansen Cleanrooms & Labs to construct a scale model
AZ Delta
Group Jansen took care of the ‘street’ including among other things, dialysis, radiotherapy, nuclear
Medace
They rents cleanrooms and laboratories to start-ups and entrepreneurs. They also provide support and
Anicells
Jansen Cleanrooms & Labs built the production facility for Anicells—located in the Science Park
Redwire Space
This facility in Kruibeke develops and supplies complete satellites and important satellite equipment, including
UZ Brussel
On behalf of UZ Brussel,we successfully completed the construction and commissioning of a state-of-the-art
AZ Sint-Maarten
Campus Rooienberg in Duffel and campuses Leopoldstraat and Zwartzustervest in Mechelen joined forces and
Accessia
Many companies face difficulties when translating laboratory discoveries into preclinical and clinical development. The
